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Abstract 27 
Ki-67 protein is widely used as a tumor proliferation marker. However, whether Ki-67 28 
affects cell cycle progression has been controversial.  Here, we demonstrate that depletion 29 
of Ki-67 in human hTERT-RPE1, WI-38, IMR90, hTERT-BJ cell lines and primary fibroblast 30 
cells slowed entry into S phase and coordinately downregulated genes related to DNA 31 
replication. Some gene expression changes were partially relieved in Ki-67-depleted 32 
hTERT-RPE1 cells by co-depletion of the Rb checkpoint protein, but more thorough 33 
suppression of the transcriptional and cell cycle defects was observed upon depletion of 34 
cell cycle inhibitor p21. Notably, induction of p21 upon depletion of Ki-67 was a consistent 35 
hallmark of cell types in which transcription and cell cycle distribution were sensitive to Ki-36 
67; these responses were absent in cells that did not induce p21. Furthermore, upon Ki-67 37 
depletion, a subset of inactive X (Xi) chromosomes in female hTERT-RPE1 cells displayed 38 
several features of compromised heterochromatin maintenance, including decreased 39 
H3K27me3 and H4K20me1 labeling. These chromatin alterations were limited to Xi 40 
chromosomes localized away from the nuclear lamina and were not observed in 41 
checkpoint-deficient 293T cells. Altogether, our results indicate that Ki-67 integrates 42 
normal S phase progression and Xi heterochromatin maintenance in p21 checkpoint-43 
proficient human cells.  44 
 45 
 INTRODUCTION 46 
Ki-67 was first identified via an antibody raised against Hodgkin lymphoma cell 47 
nuclei (1).  Because Ki-67 is generally expressed strongly in proliferating cells and poorly in 48 
quiescent cells (2), anti-Ki-67 antibodies are frequently used to detect proliferative cells in 49 
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clinical studies (3,4). In interphase cells, Ki-67 primarily localizes to the nucleolus (5-7), 50 
whereas during mitosis, it coats the chromosomes (8-10). In the past few years, several 51 
studies have greatly increased our understanding of Ki-67 function. This is particularly true 52 
for its mitotic roles. Specifically, Ki-67 is required for formation of the mitotic 53 
perichromosomal layer (11,12), a proteinaceous sheath that coats mitotic chromosomes 54 
(13,14). As part of this layer, Ki-67’s large size and highly positively-charged amino acid 55 
composition keeps individual mitotic chromosomes dispersed rather than aggregated upon 56 
nuclear envelope disassembly, thereby ensuring normal kinetics of anaphase progression 57 
(15). At anaphase onset, Ki-67 binds protein phosphatase 1γ (PP1γ) to form a holoenzyme 58 
(16) important for targeting substrates that must be dephosphorylated during mitotic exit 59 
(10). In contrast to its structural role on the mitotic chromosomal surface, Ki-67 does not 60 
appear to affect nucleosomal spacing (15) or condensation of individual mitotic 61 
chromosomes (11,15). 62 
In addition to its expression in proliferating cells, other experiments suggested Ki-63 
67 has a positive role in regulating cell proliferation. In early studies, antisense 64 
oligonucleotides targeting Ki-67 expression in human IM-9 multiple myeloma cells blocked 65 
[3H]-thymidine incorporation, indicative of inhibition of proliferation (17). Likewise, Ki-67-66 
targeted phosphorothioate anti-sense oligonucleotides that resulted in partial depletion of 67 
Ki-67 protein inhibited proliferation of human RT-4 bladder carcinoma and other tumor 68 
cell lines (18). More recently, siRNA-mediated depletion of Ki-67 resulted in reduced 69 
proliferation in human 786-0 renal carcinoma cells (19).  70 
However, despite its utility as a proliferation marker, the contribution of Ki-67 to 71 
cell proliferation has recently been questioned. For example, in one recent study, genetic 72 
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disruption of Ki-67 in human MCF-10A epithelial breast and DLD-1 colon cancer cells did 73 
not affect cell proliferation rates in bulk culture, although clonogenic growth of highly 74 
diluted cell populations was reduced (20). In another recent study, depletion of Ki-67 in 75 
human HeLa or U2OS cells did not alter cell cycle distribution (12). These data raise the 76 
possibility that Ki-67 function may have different consequences in different cell types. 77 
In our previous studies we demonstrated that the interphase and mitotic 78 
localization of Ki-67 is partially dispersed in cells lacking the N-terminal domain of the 79 
p150 subunit of Chromatin Assembly Factor-1 (21, 22). We therefore began exploring the 80 
functions of Ki-67 in several human cell types. Here, we show that the contribution of Ki-67 81 
to cell proliferation depends on cell type. In hTERT-RPE1, WI-38, IMR90, and hTERT-BJ 82 
cells and primary foreskin fibroblasts, depletion of Ki-67 resulted in reduced frequencies of 83 
S-phase cells and concomitant reduction in S phase-related transcript levels. We show that 84 
in female hTERT-RPE1 cells, these phenotypes required a p21 checkpoint-mediated delay 85 
in S phase entry, and are accompanied by altered nucleolar association and chromatin 86 
characteristics of the inactive X (Xi) chromosome. Notably, none of these phenotypes were 87 
observed in human cells unable to induce p21 in response to Ki-67 depletion. Therefore, Ki-88 
67 is important for normal S phase progression in p21 checkpoint-proficient human cells, 89 
in a manner correlated with its contribution to Xi heterochromatin composition. 90 
 91 
RESULTS 92 
Ki-67 affects S phase gene expression and progression 93 
To explore how Ki-67 impacts gene expression, we performed RNAseq analyses of 94 
control and Ki-67-depleted hTERT-RPE1 cells, a diploid retinal pigment epithelial cell line 95 
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immortalized by an hTERT transgene (23). Duplicate analyses were highly reproducible 96 
(Figures 1A-B). Ki-67 depletion resulted in approximately equal numbers of reduced and 97 
increased RNA levels across the transcriptome (Figure 1C). However, Reactome pathway 98 
analysis of RNA abundance changes showed that the most altered functional sets of genes 99 
included those involved in DNA replication and cell cycle progression (Figure 1D). For 100 
example, levels of RNAs encoding all subunits of several protein complexes involved in S 101 
phase progression were concertedly reduced, including DNA replication clamp loader RFC 102 
(RFC1-5 genes), ssDNA-binding complex RPA (RPA1-3), the replicative helicase (MCM1-6), 103 
the GINS replication initiation complex (GINS1-4), the DNA polymerase alpha/primase 104 
complex, as well as the DNA replication clamp PCNA and the flap-endonuclease FEN1 105 
involved in Okazaki fragment maturation (Supplemental Tables 1-2). We confirmed 106 
reduced levels of a subset of replication-related RNA targets by RT-qPCR analyses (Figures 107 
1E-F). Notably, the RT-qPCR data were very similar when obtained with two distinct Ki-67 108 
depletion reagents, one a synthetic siRNA and the other a cocktail of in vitro-diced dsRNAs 109 
non-overlapping the siRNA target, both of which efficiently depleted steady-state Ki67 110 
levels (Figures 1M-N).  111 
We also observed that fluorescence-activated cell sorting (FACS) analysis of Br-112 
dUTP-labeled cells showed that the proportion of S phase cells decreased upon depletion of 113 
Ki-67 in hTERT-RPE1 cells with either depletion reagent (Figure 1G-H; quantified in Fig. 1I 114 
and 1K).  In contrast, proportions of G1 and G2/M populations were not significantly 115 
altered (Fig. 1J and 1L). Therefore, Ki-67 is important for normal S phase distribution and 116 
gene expression in hTERT-RPE1 cells.  117 
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As an additional control for the direct effect of the siRNA treatment, we used 118 
CRISPR/Cas9 to mutate the siRNA target site in hTERT-RPE1 cells (Fig. 2A-B). In a resulting 119 
homozygous mutant cell line (Figure 2C), siKi-67 no longer depleted Ki-67 protein levels, 120 
but as expected the esiKi-67 reagent was still effective (Figure 2D). We also observed that 121 
siKi-67 no longer altered candidate S phase RNA levels in the resistant cell line, but esiKi-122 
67 did (Figure 2E). We conclude that the transcriptional response to acute depletion of the 123 
Ki-67 mRNA is due to loss of Ki-67 protein.  124 
 However, recent studies challenge the view that Ki-67 is important for human cell 125 
proliferation; for example, depletion of Ki-67 had minimal effects on the cell cycle 126 
distribution of tumor-derived HeLa or U2OS cells (12). Because our data indicated that Ki-127 
67 contributes to normal cell cycle progression in hTERT-RPE1 cells, we hypothesized that 128 
the contribution of Ki-67 to cell cycle progression would be cell type-dependent, and may 129 
be related to checkpoint function. To explore this idea, we depleted Ki-67 in several 130 
additional cell lines. We compared diploid, non-immortal WI-38 and IMR90 fibroblasts, 131 
hTERT-immortalized BJ fibroblasts, and primary human foreskin fibroblasts (HFFs) with 132 
tumor-derived cell lines: virally-transformed kidney (293T) or cervical carcinoma (HeLa) 133 
cells, and osteosarcoma U2OS cells. Importantly, we confirmed that all these cells could be 134 
efficiently depleted of Ki-67 protein using both of our depletion reagents (Figure 2F-L).  135 
In all of the experiments with the non-tumor-derived cells, we observed reduced 136 
replication factor RNA levels and fewer cells in S phase, similar to our results in hTERT-137 
RPE1 cells, and these results were independent of which Ki-67 depletion reagent was used 138 
(Figures 3-4). In contrast, in the tumor-derived cell lines, Ki-67 depletion did not result in 139 
uniform down regulation of the S phase genes tested, nor were there changes in cell cycle 140 
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distribution (Figures 5-6). These data are consistent with RNAseq data sets in HeLa and 141 
U2OS cells (12) that did not display concerted downregulation of DNA replication genes. 142 
We conclude that the effects of Ki-67 depletion on RNA levels and cell cycle distribution are 143 
cell type-dependent.  144 
The FACS analyses of asynchronous cell populations indicated that Ki-67 depletion 145 
most significantly affects S phase in the sensitive cell types. To examine this in more detail, 146 
we analyzed the kinetics of DNA synthesis in synchronized hTERT-RPE1 cells. Cells were 147 
blocked near the G1-S transition of the cell cycle with hydroxyurea (HU) for 15 hours 148 
(Figure 7A) (24), which provided efficient arrest (Fig. 7D). Cells were then released into 149 
drug-free media and pulse-labeled with the deoxynucleotide analog EdU at two-hour 150 
timepoints across an 8-10-hour time course. In control cells treated with the scrambled 151 
siRNA, EdU labeling was first detected at the 2 hour time point, and displayed a typical 152 
early S phase pattern consisting of many small foci (25). At later time points, the pulse of 153 
EdU labeled larger foci, indicative of mid-late S phase patterns. Upon Ki-67 depletion, we 154 
observed a delay in the initial detection of EdU incorporation of approximately 2 hours 155 
(Figure 7B). Notably, the Ki-67-depleted population also displayed a higher percentage of 156 
cells that did not incorporate EdU during the time course (Figure 7C). Together, these data 157 
are consistent with our transcriptomic and FACS data indicating that Ki-67 depletion 158 
affects S-phase in hTERT-RPE-1 cells (Figure 1). 159 
 160 
Checkpoint responses to Ki-67 depletion 161 
Because Ki-67 depletion did not affect S phase transcription or cell cycle 162 
progression in tumor-derived cell lines, our data suggested that functional checkpoints are 163 
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required for sensitivity to Ki-67 depletion.  Consistent with this idea were comparisons of 164 
our RNAseq data with metadata analyses of genes regulated by cell cycle status or by E2F 165 
transcription factors (26) that are important for G1/S cell cycle phase transcription (26-166 
28). These meta-analyses aggregated multiple datasets, finding that similar results in 167 
multiple datasets strongly predicted regulatory network connections that could be missed 168 
in single experiments. Of the cell cycle-regulated genes identified in that study, we find 169 
those that peak during G1/S phase were more frequently downregulated than upregulated 170 
upon Ki-67 depletion (Fig. 8A; Supplemental Table 3). Consistent with this observation, 171 
E2F target RNA levels (Fig. 8B) were much more frequently downregulated than 172 
upregulated upon Ki-67 depletion. These comparisons were consistent with the idea that 173 
checkpoint activation contributed to the observed delay in S phase entry and 174 
transcriptional phenotypes in Ki-67-depleted cells. 175 
To test this, we performed experiments co-depleting checkpoint proteins. First, we 176 
took advantage of a derivative of hTERT-RPE1 cells that have an integrated, doxycycline-177 
inducible shRNA that targets the RB mRNA (29). Rb levels remained unchanged in these 178 
cells in the absence of doxycycline (Fig. 8C), and siRNA-mediated depletion of Ki-67 179 
resulted in reduced S phase-related RNA levels as was observed previously (Fig. 8D). 180 
Addition of doxycycline to deplete Rb, together with a control scrambled siRNA leaving Ki-181 
67 levels unchanged, did not significantly alter S-phase related target RNA levels (Fig. 8D). 182 
In contrast, simultaneous depletion of Rb and Ki-67 resulted in RNA levels at two of the 183 
four loci tested that were significantly elevated compared to those in cells depleted of Ki-67 184 
alone (Fig. 8D). FACS analysis indicated that Rb depletion was insufficient to significantly 185 
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change the cell cycle profile of Ki-67-depleted cells (Fig. 8E-F). We conclude that depletion 186 
of Rb only partially relieves the cellular response to Ki-67 depletion in hTERT-RPE1 cells. 187 
Therefore, we reasoned other factors must contribute. One clue was provided by 188 
comparison of the si-Ki-67 RNAseq data to metadata analysis of binding by subunits of the 189 
transcription repressor complex termed DREAM (26). We observed that genes with the 190 
highest predicted probability of DREAM binding were very frequently downregulated upon 191 
Ki-67 depletion (Fig. 8G). In mammalian cells, DREAM is a master regulator of cell cycle-192 
dependent gene expression, repressing both G1/S and G2/M targets, and gene repression 193 
by DREAM requires the p21 checkpoint protein (27,30,31). p21 is a potent universal CDK 194 
inhibitor (CKI). During G1 and S phases, p21 directly binds to and inhibits the kinase 195 
activity of cyclin E-CDK2, cyclin B1-CDK1 and cyclin D-CDK4/6 complexes (32-34). 196 
Furthermore, p21 also directly inhibits DNA synthesis by binding to PCNA, the sliding 197 
clamp required for processive DNA polymerase activity (35). Therefore we hypothesized 198 
that p21 could be important for the response to Ki-67 depletion (Figure 8H). 199 
Consequently, we next tested effects of Ki-67 depletion the CDKN1A gene, which 200 
encodes p21. Our RNAseq data indicated increased CDKN1A RNA levels in Ki-67 depleted 201 
hTERT-RPE1 cells (log2 fold change = +0.48, p = 0.016), although multiple hypothesis 202 
testing indicated that these values did not achieve the stringent statistical significance 203 
cutoff of q < 0.05 (Supplemental Table 2). RT-PCR measurements of CDKN1A RNA levels 204 
demonstrated a significant increase in four diploid cell types, but not in 293T cells (Fig. 205 
9A). We note that induction of CDKN1A RNA was dependent on having an intact siRNA 206 
target site in the Ki-67 gene, indicating this is a direct effect of Ki-67 depletion (Figure 2E). 207 
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Consistent with the increased RNA levels, we detected elevated p21 protein levels in 208 
hTERT-RPE1 but not 293T cells (Fig. 9B).  209 
p21 is a direct target of transcriptional induction by the tumor suppressor p53, and 210 
the cell lines examined thus far therefore implicated active p53 in the sensitivity to Ki-67  211 
(36,37). To examine this relationship further, we compared the effects of Ki-67 depletion in 212 
additional cancer cell lines, including two expressing wild-type p53, MCF7 and HCT116, 213 
and also MDA-MB-231 cells which express a mutant p53 defective for p21 induction (38).  214 
In MCF7 breast adenocarcinoma cells, we observed that Ki-67 depletion elevated p21 RNA 215 
and protein levels (Fig. 9 G,H), and down-regulated replication-related RNAs (Fig. 9H).  In 216 
contrast, in HCT116 colorectal carcinoma and MDA-MB-231 breast adenocarcinoma cells, 217 
Ki-67 depletion did not increase p21 expression or cause concerted down-regulation of S 218 
phase genes (Fig. 9G, I, J). Because HCT116 and MDA_MB-231 cells differ in their p53 219 
status, we conclude that p53 status cannot always predict the response to Ki-67 depletion. 220 
Instead, we find that induction of p21 upon Ki-67 depletion is a consistent hallmark of this 221 
form of checkpoint activation.  222 
To assess the functional consequence of p21 induction, we performed co-depletion 223 
experiments in hTERT-RPE1 cells (Fig. 9D). We observed that cells simultaneously 224 
depleted of both Ki-67 and p21 no longer displayed the reduced levels of any of the four S 225 
phase-related mRNAs analyzed (Fig. 9D). Furthermore, FACS analysis of the co-depleted 226 
cells showed that there was significant restoration of the percentage of cells in S phase 227 
upon codepletion of p21 with Ki-67 (Fig. 9E-F). We conclude that induction of p21 is 228 
functionally important for the effects of Ki-67 depletion on cell cycle distribution in hTERT-229 
RPE1 cells.  230 
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Ki-67 affects heterochromatic characteristics of the inactive X chromosome 231 
Ki-67 is required for the normal cellular localization of heterochromatin-associated 232 
histone modifications (12), and for the interphase nucleolar association of heterochromatic 233 
loci(22). Because the inactive X (Xi) chromosome is a well-studied example of facultative 234 
heterochromatin that associates with the nucleoli of female mouse (24) and human cells 235 
(39-41), we tested whether Ki-67 affected characteristics of Xi heterochromatin. Indeed, Ki-236 
67 depletion in hTERT-RPE1 cells resulted in a subset of cells that displayed reduced 237 
staining intensity for antibodies recognizing H3K27me3 and H4K20me1, histone 238 
modifications that are enriched on the Xi (42,43)(Figure 10A, C, E, G). H3K27me3 is 239 
generated by the Polycomb PRC2 complex and is a keystone of facultative heterochromatic 240 
silencing (44-46). H4K20me1 is generated by the PR-Set7/Set8/KMT5a enzyme (47) and 241 
together with H3K27me3 is an early mark on Xi chromosomes during the process of XIST-242 
mediated inactivation (43,47). Notably, changes to either of these histone modifications 243 
were only observed in cells in which the Xi was localized away from the nuclear periphery 244 
(Fig. 10B, D, F, H). Furthermore, these changes were not observed in 293T cells that also 245 
lacked the cell cycle response to Ki-67 depletion (Fig. 11). Therefore, the response of 246 
hTERT-RPE1 cells to Ki-67 depletion involves two classes of correlated events that are both 247 
absent in 293T cells: checkpoint-mediated perturbation of S phase, and altered Xi 248 
heterochromatin. 249 
Increased levels of repetitive element-rich Cot-1-hybridizing transcripts and RNA 250 
polymerase II have previously been observed in breast cancer cell lines that display 251 
perturbations in Xi chromatin (48). We tested for changes in these properties as well, and 252 
we detected an increase in the frequency of cells that display Cot-1-hybridizing transcripts 253 
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or RNA polymerase II on the Xi upon Ki-67 depletion in hTERT-RPE1 cells (Figures 12-13). 254 
As observed above for the histone modifications (Fig. 10), increased levels of Cot-1 RNA 255 
and Pol II within the XIST domain were only observed in cells in which the Xi was localized 256 
away from the nuclear periphery. Also, as for all other phenotypes detected, these changes 257 
were similar with either Ki-67 depletion reagents (Figs. 12-13).  258 
However, not all aspects of Xi heterochromatin were sensitive to Ki-67 depletion. 259 
For example, Ki-67 depletion did not alter the overall appearance of the XIST “cloud” that 260 
covers the Xi (Fig. 14A).  In addition, RT-PCR showed no significant down regulation of 261 
XIST transcript expression (Fig. 10J).  Also, there was no evidence for Xi chromosome-wide 262 
deprepression of transcription, as shown in the analysis of X-linked gene expression (Fig. 263 
14B), or in the analysis of allele-specific transcription of X-linked genes detected via 264 
analysis of known SNPs (Supplemental Table 4). Furthermore, an additional mark 265 
associated with the Xi, the histone variant macroH2A, did not change in appearance upon 266 
depletion of Ki-67 (Fig. 14C-H). Together, the Xi data indicate that acute depletion of Ki-67 267 
alters several, but not all, characteristics of Xi heterochromatin in hTERT-RPE1 cells. 268 
Importantly, changes in H3K27me3 and H4K20me1 staining were not observed in 293T 269 
cells, indicating a correlation between checkpoint activation and effects on the Xi upon Ki-270 
67 depletion. 271 
 272 
Ki-67 affects the S phase nucleolar association of the inactive X chromosome 273 
The perinucleolar space is a subset of the heterochromatic compartment; another 274 
frequent location for heterochromatin is at the nuclear periphery, adjacent to the nuclear 275 
lamina (49). Accordingly, the Xi is usually localized to one of these two preferred locations 276 
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(24). However, heterochromatic sequences can dynamically relocalize from nucleoli to the 277 
periphery, either during cell division or upon perturbing the nucleolus with actinomycin 278 
(49-52). Because Ki-67 depletion affected heterochromatic marks only on Xi chromosomes 279 
away from the nuclear periphery (Figs. 10-13), we hypothesized that it might also affect the 280 
interphase localization of the Xi. We first examined Xi localization in asynchronous hTERT-281 
RPE1 cells, using immuno-RNA-FISH to detect Xi-associated lncRNA XIST and nucleolar 282 
protein fibrillarin. Indeed, Ki-67 depletion resulted in a partial but statistically significant 283 
reduction in Xi-nucleolar associations (Figure 15A-D). This loss of nucleolar association 284 
was accompanied by an increase of similar magnitude in Xi-lamina associations, and 285 
similar results were observed with our two distinct Ki-67 depletion reagents (Figures 15B, 286 
D). However, in 293T cells, we observed no significant alteration in Xi-nucleolar 287 
associations (Fig. 15E-H). Thus, distribution of the Xi within the interphase nucleus is 288 
sensitive to Ki-67 depletion in a cell type that induces p21.  289 
Previous studies in mouse cells showed that the Xi-nucleolar association is cell-cycle 290 
regulated, occurring most prevalently in S phase cells (24). Therefore, we examined Xi 291 
localization in hTERT-RPE1 cells prepared in the same manner as in the cell 292 
synchronization experiments in Figure 7A-B. Consistent with published data from mouse 293 
cells (24), the frequency of Xi-nucleolar associations peaked in middle S-late S phase 294 
transition; this was true for the frequency of Xi associations that were exclusively at the 295 
nucleolus (Fig. 15I), and for the frequency of Xi chromosomes simultaneously associated 296 
with both the nucleolus and the lamina (Fig. 15J). These peaks occurred in both the control 297 
and Ki-67-depleted populations, with the Xi-nucleolar interaction peaks delayed two hours 298 
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in the latter case. The two-hour shift correlates with the delay in S phase entry in the Ki-67-299 
depleted cells  (Fig. 7). 300 
As suggested by the Xi localization data from asynchronous cells (Fig. 15A-D), Xi 301 
associations with the nucleoli and lamina were inversely related, so that the peak of 302 
nucleolar associations (Figure 15I-J) coincided with the lowest frequencies of laminar 303 
associations (Fig. 15K). We note that when the total Xi-laminar association frequencies 304 
were counted by summing the exclusively laminar associations (Fig. 15K) plus those also 305 
associated with nucleoli simultaneously (Fig. 15J), we observed little change during the 306 
experiment (Figure 15L). Thus, the biggest changes during S phase are lamina-associated Xi 307 
becoming transiently also associated with nucleoli (e.g. compare Fig. 15J and 15K). 308 
Together, these data indicated that cell cycle-regulated Xi-nucleolar associations are 309 
delayed in concert with DNA synthesis upon depletion of Ki-67 in hTERT-RPE1 cells. Thus, 310 
checkpoint activation upon Ki-67 depletion affects cell cycle progression and gene 311 
expression, and these effects are correlated with altered Xi heterochromatin in female 312 




Cell-type specific responses to Ki-67 depletion 317 
Our studies show that Ki-67 expression is important for normal S phase progression 318 
in primary human foreskin fibroblasts, non-transformed fibroblast lines (WI-38 and 319 
IMR90), hTERT-immortalized BJ fibroblasts, and hTERT-immortalized RPE1 cells (23), a 320 
human female retinal pigment epithelial cell line with a diploid karyotype (53). In contrast, 321 
in cancer-derived 293T, U2OS and HeLa cells, depletion of Ki-67 did not cause defects in 322 
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cell proliferation. Therefore, we conclude that Ki-67 is required for normal cell cycle 323 
progression in some but not all cell lines. Our data distinguish two types of responses to 324 
depletion of Ki-67 in human cells, depending on whether cells are able to mount a p21-325 
dependent checkpoint. 326 
hTERT-BJ fibroblasts were sensitive to Ki-67 depletion in our assays; however, a 327 
previous study indicated that shRNA-mediated Ki-67 depletion did not affect hTERT-BJ cell 328 
cycle re-entry after starvation (12). Therefore, not all assays can detect the effects of Ki-67 329 
depletion. For example, two assays used in the previous study are insensitive to the cell 330 
cycle progression delays that we observe upon Ki-67 depletion. First, one-dimensional flow 331 
cytometry of propidium iodide-stained asynchronous populations cannot detect the S 332 
phase delays we detect in BrdU labeling experiments; second, a 3 hour EdU pulse is too 333 
long to capture the 2-hour S phase entry delay. Together, our data indicate that the effects 334 
of Ki-67 on S phase progression are transient in sensitive cell types and therefore most 335 
easily observed using short pulses of labeled deoxynucleotides.  336 
 337 
Characteristics of checkpoint activation caused by Ki-67 depletion 338 
Meta-analyses of our RNAseq data showed that Ki-67 depletion in hTERT-RPE1 cells 339 
resulted in frequent repression of Rb/E2F-regulated, G1/S expressed genes. However, 340 
depletion of the Rb checkpoint protein only partially relieved transcriptional repression 341 
and did not restore normal percentages of S phase cells, indicating that additional factors 342 
were responsible for the altered cell cycle profile in Ki-67 depleted cells.  343 
A strong candidate for such a factor is the DREAM complex, which represses G1/S-344 
expressed cell cycle genes in a p21-dependent manner (26, 54). We noticed frequent 345 
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downregulation of DREAM complex targets in Ki-67-depleted cells, which lead us to test 346 
whether sensitivity to Ki-67 depletion was also p21-dependent. Notably, both the 347 
transcriptional alterations and cell cycle perturbations caused by Ki-67 depletion were 348 
partially relieved by simultaneous depletion of p21. Importantly, cell lines that induce p21 349 
upon Ki-67 depletion are those that inhibit transcription of DNA replication genes and 350 
delay entry into S-phase. Thus, this study implicates a p21-dependent checkpoint in cells 351 
sensitive to Ki-67 depletion.  352 
A recent study shows that PD0332991, a small molecule CDK4/CDK6 inhibitor 353 
(CDKi), depletes Ki-67 protein levels in some but not all cell lines (55). In “CDKi-sensitive” 354 
cells, this compound causes G1 cell cycle arrest via an Rb-mediated checkpoint, inhibiting 355 
Ki-67 and cyclin A gene transcription while proteasome-mediated degradation destroys 356 
existing Ki-67 protein molecules. CDKi-sensitivity appears similar to many of the responses 357 
we observe upon Ki-67 depletion, and CDKi-sensitive cells include IMR90 and primary 358 
fibroblasts that we found to be “Ki-67 sensitive”. MCF7 breast adenocarcinoma cells are 359 
also CDKi-sensitive (55), and we find that upon Ki-67 depletion MCF7 cells induce p21 and 360 
down-regulate DNA replication genes. In contrast, HeLa and U2OS cells are not sensitive to 361 
either CDKi or Ki-67 depletion. Thus, depletion of Ki-67 via CDKi treatment (55) or via 362 
siRNA (this work) often leads to similar outcomes.  363 
However, there is a counterexample to these correlations. CDKi treatment blocks S 364 
phase entry and depletes Ki-67 in MDA-MB-231 breast adenocarcinoma cells (55). In 365 
contrast, upon Ki-67 depletion, MDA-MB-231 cells did not display either p21 induction or 366 
transcriptional down-regulation of S phase genes. Therefore, proteasome-mediated 367 
degradation of Ki-67 via CDK4/6 inhibition is not equivalent to siRNA-mediated Ki67 368 
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depletion in all cell types. We hypothesize that a key difference is related to induction of 369 
p21 in “Ki-67-sensitive” cell lines. p21 contributes to G1/S arrest via multiple mechanisms. 370 
As a CDK inhibitor (32,33), p21 blocks CDK-mediated Rb phosphorylation thereby 371 
inhibiting E2F-driven transcription(56). Likewise, it maintains activity of the 372 
transcriptionally repressive DREAM complex which contain Rb-related p107/p130 “pocket 373 
protein” subunits (26,27,54).  p21 also directly interacts with PCNA and directly inhibits 374 
DNA synthesis (35). Therefore, the lack of p21 induction in MDA-MD-231 cells may be the 375 
key factor explaining the lack of “Ki-67 sensitivity” in this cell line. Future experiments will 376 
be required to determine whether the activation of the DREAM complex or direct inhibition 377 
of DNA synthesis machinery is more important for the “Ki-67-sensitive” phenotype 378 
associated with p21 induction.  379 
Regarding the defect in p21 induction in MDA-MB-231 cells, we note that they 380 
express a gain-of-function R280K allele, which dominantly blocks p21 induction (38). Thus, 381 
p53 status is likely a critical aspect of the different cell cycle responses to Ki-67 depletion in 382 
many cell lines. However, sensitivity to Ki-67 depletion cannot always be predicted strictly 383 
by p53 status. For example, HCT116 cells express wild-type p53 (38) but are not sensitive 384 
to the CDKi PD0332991 (55), or to Ki-67 depletion (Fig. 9J). Because Ki-67 expression 385 
predicts the differential response of different cell lines to CDKi treatment during xenograft 386 
tumor formation (55), understanding how different checkpoint mutations alter Ki-67 387 
expression and sensitivity to its depletion are important goals for developing stratified 388 
approaches to cancer therapies.  389 
 390 
Ki-67 contributes to the interphase localization of the Xi chromosome 391 
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Nucleoli are non-membrane bound organelles within the nucleus. Not only are these 392 
sites of synthesis and assembly of ribosome components, the periphery of these organelles 393 
plays an important role in higher order chromosome localization (49,57). Specifically, the 394 
nucleolar periphery houses a subset of the cellular heterochromatin, which exchanges 395 
dynamically with lamina-associated heterochromatin (50-52). Like other heterochromatin 396 
regions, high resolution analysis of nucleolus-associated domains (termed NADs) in human 397 
cells reveals enrichment of satellite repetitive DNAs and repressive histone marks 398 
(51,58,59). Major questions in chromosome biology are how heterochromatin regions are 399 
partitioned to different intranuclear locations, and how these interactions are governed by 400 
cell cycle progression.  401 
As a region of facultative heterochromatin, the Xi chromosome in female cells is 402 
enriched in NAD loci, usually localized to either the nucleolar periphery or to the nuclear 403 
lamina (24,40,58) . In mouse cells, the Xi-nucleolar association is cell cycle-dependent, with 404 
frequencies peaking during mid-to-late S phase. A genetic deletion was used to show that 405 
the long non-coding RNA Xist, which is expressed from the Xi chromosome, is required for 406 
normal Xi-perinucleolar localization. Deletion of Xist results in diminished H3K27me3 407 
enrichment and increased synthesis of Cot-1-hybridizing, repeat-derived RNAs on the Xi 408 
(24). These data suggest that perinucleolar localization of Xi contributes to the 409 
maintenance of heterochromatin structure. More recently, depletion of long non-coding 410 
RNA Firre was shown to reduce association of the Xi to nucleolus in mouse cells, and also 411 
reduces H3K27me3 density on the Xi (60). However, Firre depletion has minimal effects on 412 
Xi gene silencing, consistent with the idea that multiple functionally overlapping factors 413 
affect Xi heterochromatin localization and gene silencing. 414 
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 Here, we discovered that Ki-67 affects the Xi-nucleolus interaction. Analysis of 415 
synchronized RPE-1 cells shows that the association appears more slowly in Ki-67-416 
depleted cells, coincident with the delay in S phase entry. In addition to this delay, Ki-67 417 
depletion alters some of the heterochromatin characteristics of the Xi, causing significantly 418 
increased levels of Cot-1-hybridizing RNAs and Pol ll, and decreased enrichment of 419 
H3K27me3 and H4K20me1. This loss of heterochromatic properties is partial in the cell 420 
population, and we do not detect uniform reactivation of Pol II genes on the Xi. These data 421 
are consistent with previous studies showing that multiple overlapping mechanisms 422 
maintain the inactive status of the Xi (60,61). We note that XIST levels are not reduced 423 
upon Ki-67 depletion (Supplemental Table 2; Fig. 10), suggesting that altered XIST levels 424 
are unlikely to explain the effect of Ki-67 on the Xi. Instead, our data is consistent with the 425 
view that Ki-67 is one of the factors that contributes to the maintenance of heterochromatic 426 
structures of the Xi (12) in this case in a manner coupled to S phase progression.   427 
Recent data show that the nuclear lamina localization mediated by the interaction 428 
between XIST and the lamina B receptor facilitates the spreading of XIST on the Xi 429 
chromosome, which in turn contributes to transcriptional silencing (62). This raises the 430 
question of whether there are specific protein factors that contribute to the association of 431 
the Xi with the nucleolus in addition to the lncRNAs XIST and FIRRE (24,60). Could Ki-67 be 432 
such a factor? In support of this idea, Ki-67 is also required for association of other 433 
heterochromatic regions with nucleoli in interphase cells (11,12,22). 434 
It appears that the erosion of heterochromatic features on the Xi occurs in a 435 
significant fraction of Ki-67-depleted cells away from the nuclear lamina, but the lamin-436 
associated Xi chromosomes are not altered. There are two possibilities to explain these 437 
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data. First, it may be that lamina association confers protection from heterochromatin 438 
changes. Alternatively, Xi chromosomes that are most severely affected by Ki-67 depletion 439 
may preferentially relocalize away from the lamina. Because our shRNA-based experiments 440 
necessitate a 72-hour period to achieve strong Ki-67 depletion, there is likely passage 441 
through multiple mitoses for each cell during this period. As Ki-67 is a key component of 442 
the perichromosomal layer that envelopes each mitotic chromosome (11,15), it is tempting 443 
to speculate that the loss of Ki-67 affects the reassociation of heterochromatic sequences 444 
with the nuclear lamina or nucleoli after mitotic exit.  445 
 446 
Materials and Methods 447 
Antibodies and Immunoblotting 448 
The following antibodies were used in this work: 449 
rabbit anti-Ki-67  (Abcam Ab15580) 450 
mouse anti-beta-tubulin (Ubpbio Y1060) 451 
rabbit anti-fibrillarin (Abcam ab5821-100) 452 
mouse anti-BrdU antibody (MoBu-1) (Abcam ab8039) 453 
mouse anti-p21 antibody (Abcam  ab109520) 454 
rabbit anti-mcroH2A.1 (Abcam  ab37264) 455 
mouse anti-Rb antibody (4H1) ( Cell signaling  9309) 456 
mouse anti-H4K20Me1 (Active motif  39727) 457 
mouse anti-RNA polymerase II, clone CTD4H8 (Millipore 05-623) 458 
mouse anti-nucleophosmin (Santa Cruz Biotechnology sc-32256)   459 
rabbit anti-WSTF (Cell signaling  2152) 460 
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rabbit anti-H3K27Me3 (Active motif  39535) 461 
 462 
Amersham ECL Rabbit IgG, HRP-linked whole Ab (GElifescience NA934) 463 
Donkey anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor® 594 (Life Technologies A-464 
21207) 465 
Donkey anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor® 488 (Life Technologies  466 
A-21206) 467 
Streptavidin, Alexa Fluor® 488 Conjugate (Invitrogen S-32354) 468 
DyLight 594 Labeled Anti-Digoxigenin/Digoxin (Vector Labs DI-7594) 469 
For immunoblotting, cells were collected 3 days after RNAi transfection. Whole-cell lysates 470 
were extracted in 20 mM Tris-HCl 7.5, 1% SDS and 10% glycerol supplemented with 471 
protease inhibitor cocktail (Sigma P8340-1ml). The lysates were sonicated in a Bioruptor 472 
set on high power for one 5 min cycle, with 30s on/30s off. 15 g of each lysate were 473 
separated by SDS-PAGE, transferred to PVDF membrane and probed as described in the 474 
figure legends. 475 
 476 
Cell Cultures 477 
hTERT-RPE1 cells (a kind gift from Dr. Judith Sharp) and hTERT-BJ were cultured in 478 
DMEM-F12 medium (VWR 12001-600) with 10% fetal bovine serum (FBS, Hyclone 479 
#SH30910.03), 1% penicillin/streptomycin, 5% L-glutamine and 7.5% sodium bicarbonate 480 
solution.  481 
 HeLa and U2OS cells were propagated in DMEM medium supplemented with 10% fetal 482 
bovine serum. Cells were maintained > 25% confluence and passaged every three days.  483 
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Human foreskin fibroblasts (HFF, a kind gift from Dr. Jennifer Benanti, University of 484 
Massachusetts Medical School (63) were maintained in DMEM containing 10% FBS and 485 
antibiotic/antimycotic solution. HFF cells were grown at >25% confluence and were split 486 
1:4 every 2 days. All cells were maintained in a 37 OC incubator with 5% CO2.  487 
WI-38 cells were maintained in DMEM and supplemented with 10% FBS, 2 mM L-488 
glutamine and antibiotic/antimycotic solution (Life Technologies, Carlsbad, CA). WI-38 489 
cells were grown at >25% confluence and were split 1:4 every 2 days.  490 
IMR-90 and MDA-MB-231 were maintained in DMEM medium with 10% FBS, 2mM L-491 
glutamine, and antibiotic/antimycotic solution. The cells were cultured at >25% confluence 492 
and were split every 2 days. 493 
HCT 116 (a kind gift of Dr. Anastassiia Vertii, University of Massachusetts Medical School) 494 
and 293T cells were cultured in DMEM medium with 10% FBS. The cells were split 1:4 495 
every 3 days 496 
MCF7 cells were grown in RPMI medium with 10% FBS. The cells were split 1:3 every 3 497 
days. 498 
For hydroxyurea treatment, hTERT-RPE1 cells were cultured in the presence of 2 mM 499 
hydroxyurea for 15 h, then washed with three times phosphate-buffered saline (PBS) and 500 
released into hydroxyurea-free medium and harvested at the indicated time points. 501 
 502 
sgRNA  design 503 
For editing the siRNA target site in the endogenous Ki-67 locus, four highest scoring single 504 
guide RNAs (sgRNAs) targeting nucleotides 9661-9722 of the genomic DNA  (NG_047061) 505 
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were selected by using the CRISPR Design web tool at http://crispr.mit.edu/ (64). The 506 
sgRNA sequences are shown below: 507 
5’-ACGTGCTGGCTCCTGTAAGT-3’ (antisense) 508 
5’-TCTAGCTTCTCTTCTGACCC-3’ (sense) 509 
5’-GATCTTGAGACACGACGTGC-3’ (antisense) 510 
5’- CTTCTGACCCTGGTGAGTAG-3’ (sense) 511 
These  were cloned into a variant of the pX330 plasmid (64) with a puromycin-resistance 512 
cassette (a kind gift from Kurtis McCannell and Dr. Thomas Fazzio, University of 513 
Massachusetts Medical School) as previously described (65). To determine the most 514 
efficient sgRNAs, 293T cells were transfected with FuGENE HD (Promega, catalog number 515 
E2311)  according to manufacturer’s instructions. 500 ng of sequence-verified CRISPR 516 
plasmid (pSpCas9-sgRNA) was transfected into 200 × 103 cells in 24 well dish.  48 hours 517 
post-transfection, DNA was extracted using QuickExtract DNA extraction solution 518 
(Epicentre, catalog number QE09050) according to manufacturer’s instructions.  Genomic 519 
DNA was PCR amplified using a Taq DNA Polymerase (New England Biolabs, catalog 520 
number M0273). The following primers were used for PCR amplification:  521 
F2 primer: GGGTTCCAGCAATTCTCCTG 522 
R primer: TCACCAAGGGAAAGTTAGGC 523 
514 bp PCR products were ran on agarose gel and purified using Zymoclean Gel DNA 524 
recovery kit (Zymo Research, catalog number D4007) and sent for Sanger sequencing at 525 
Genewiz sequencing facility. The following primer was used for sequencing: 526 
F primer: GCCAGGCTGTTCTCAAACTC 527 
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To assess gene editing in 293T cells by four sgRNA plasmids, TIDE web tool at https://tide-528 
calculator.nki.nl/ was used (66). Trace data for PCR fragment from GFP-transfected 293T 529 
cells were used as a control sample chromatogram, and trace data for PCR fragments from 530 
CRISPR plasmid-transfected cells were used as test sample chromatograms. The following 531 
sgRNA was selected due to its efficiency in cutting and proximity to the siRNA site:  532 
5’-GATCTTGAGACACGACGTGC-3’ (referred to as sgKi-67 from now on).  533 
 534 
Co-transfection of CRISPR plasmid and HDR template into hTERT-RPE1 cells 535 
An HDR repair template carrying the siRNA-resistance conferring mutations, EcoO109I site 536 
and 700 bp homology flanks on each side was purchased as a gBlock from Integrated DNA 537 
Technologies. The template was cloned into pCR2.1 (Thermo Fisher Scientific, catalog 538 
number K200001) according to manufacturer’s instructions.  539 
The sgKi-67 was cloned into a variant of the pX330 plasmid(64) with a neomycin-540 
resistance cassette (a kind gift from Kurtis McCannell and Dr. Thomas Fazzio, University of 541 
Massachusetts Medical School) to facilitate gene editing in hTERT-RPE1. 3.3 μg of a 1:1 542 
(v/v) mix of repair template and CRISPR plasmid were transfected using FuGENE HD into 543 
75 ×103 cells in 6 well dish. Starting 48 hours post-transfection, cells were cultured in 544 
selection medium with 800 μg/ml of G418 (Sigma-Aldrich, catalog number A1720) for 7 545 
days, with selection medium being changed every other day. Cells were recovered in G418-546 
free medium for 4 days, after which cells were trypsinized and diluted to 0.5 cells per 200 547 
μl and seeded into 96-well plates.  A week later plates were inspected for wells with single 548 
colonies, and 4 days after that replica plated into 2× 96-well plates. One plate was frozen 549 
down, the second one used to maintain and passage the cells. Once cells on the third plate 550 
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were at least ~70% confluent, DNA was extracted using QuickExtract DNA extraction 551 
solution and PCR amplified using the following primers.  552 
F3 primer: TGGCCCATTTATGAGAAAACTGA 553 
R2 primer: GGGAACAGACTTCAATTCTCCA 554 
1523 bp PCR products were further digested with EcoO109I restriction enzyme (New 555 
England Biolabs, catalog number R0503S). PCR products from successfully integrated 556 
clones were expected to be digested at 751 and 772 bp. PCR products for clones positive 557 
for the EcoO109I digested bands were ran on agarose gel, purified using  Zymoclean Gel 558 
DNA recovery kit and sent to Genewiz for Sanger sequencing. Primers F2 and R2 shown 559 
above were used for Sanger sequencing. 560 
 561 
Immunofluorescence 562 
Cells grown on glass coverslips were fixed in 4% paraformaldehyde for 10 min and then 563 
permeabilized with 0.5% Triton X-100 for 10 min at room temperature. The fixed cells 564 
were blocked in 5 % goat serum for 30 min, and incubated in primary antibody at 37 OC in 565 
a humidified chamber for 1h.  The cells were washed with PBS for 5 min three times, 566 
incubated with secondary antibody for 1 h at 37 OC in humidified chamber, followed by 567 
three PBS washes, 5 min each. Slides were then incubated with 130 ng/ml 4,6-diamidino-2-568 
phenylindole (DAPI) for 5 min and mounted in Vectashield mounting medium (Vector Lab, 569 
H-1000) 570 
Images were taken on a Zeiss Axioplan2 microscope with a 63× objective. Entire cells were 571 
imaged via Z stacks taken at 200 nm step-intervals. Approximately 25 stacks were taken 572 
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per cell, and displayed as 2D maximum intensity projections generated using AxioVision 573 
version 4.6.  574 
The Xi-nucleolar association frequencies were scored in a blinded manner. Entire cells 575 
were imaged via Z stacks taken at 200 nm step-intervals. Approximately 25 stacks were 576 
taken per cell, and displayed as 2D maximum intensity projections generated using 577 
AxioVision version 4.6. The Xi-nucleolar association frequencies on individual coverslips 578 
were scored in a blinded manner. The criteria for Xi-nucleolar or lamina association was 579 
that there were no pixels between the fluorescence signals from the XIST FISH probe and 580 
fibrillarin immunostaining (for nucleolar association) or DAPI staining of the nuclear edge 581 
(for lamina association). Densitometry of individual immunostained cells was performed in 582 
Image J 10.2 (48), using the macro script of the RGB Profiles Tool for all experiments. The 583 
quantifications of H3K27me3, macroH2.A and H4K20me1, Cot-1 and Pol II enrichment 584 
were also performed in Image J 10.2 (48). 585 
 586 
Visualization of 5-ethynyl-2-deoxyuridine(EdU)-labeled nascent DNA  587 
hTERT-RPE1 cells were grown on glass coverslips in DMEM/F12 media as described above. 588 
5-ethynyl-2-deoxyuridine (EdU) was added to the culture medium at concentration of 10 589 
M for 20 min. After labeling, cells were washed three times with PBS. Cells were then 590 
permeablized in 0.5% Triton X-100 for 30 seconds and then fixed in 10% formaldehyde for 591 
10 min.  Cells were then rinsed twice with PBS and then incubated 30 min in 100 mM Tris-592 
HCl pH 8.5, 1 mM CuSO4 , 100 mM ascorbic acid plus 50 mM carboxyrhodamine 110-azide 593 
for click-chemistry labeling. After staining, the cells on coverslips were washed three times 594 
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with PBS plus 0.5% Triton X-100, 5 min each. Cells were then counterstained with DAPI, 595 
mounted in Vectashield and imaged by fluorescence microscopy as above.  596 
 597 
Immuno-RNA-FISH and RNA-FISH 598 
The plasmid pGIA which contains human XIST exons 4, 5 and 6 was a gift from Dr Judith 599 
Sharp. Cot-1 probe was from Invitrogen (Sigma 11581074001). The probes were labeled 600 
either with biotin-14-dCTP or digoxigenin-11-dUTP using the BioPrime DNA labeling 601 
system (Invitrogen 18094-011).  602 
For immunofluorescence (IF) combined with RNA-FISH, IF was performed first as above. 603 
Cells were then re-fixed in 4% paraformaldehyde for 10 min at room temperature. The 604 
cells were then dehydrated in 75%, 85%, 95% and 100% ethanol for 2 min each.  605 
 606 
Approximately 150 ng of each probe was mixed with 20 μg single-stranded salmon sperm 607 
DNA (Sigma-Aldrich) and 12 μg E. coli tRNA and then air-dried in a speed vacuum, 608 
resuspended in 20 l 50% formamide / 50% hybridization buffer (20% Dextran Sulfate in 609 
4× SSC), denatured at 80 OC for 10 min and pre-annealed at 37 OC for 30 min prior to 610 
hybridization. Hybridizations were performed overnight in a humidified chamber at 37OC. 611 
The next day, cells were washed for 20 min in 50% formamide in 2× SSC at 37°C and then 612 
for 20 min in 2× SSC at 37°C and 20 min in 1× SSC at 37°C. The hybridized probes were 613 
detected by incubation with either Alexa fluor-488 conjugated to streptavidin (Invitrogen 614 
S-32354) or Dylight 594 labeled anti-Digoxigenin/Digoxin (Vector Labs, DI-7594) at 1:500 615 
dilutions for 60 min in a 37OC humid chamber. After incubation, slides were washed twice 616 
.CC-BY-NC-ND 4.0 International licensepeer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not. http://dx.doi.org/10.1101/134767doi: bioRxiv preprint first posted online May. 5, 2017; 
 28
in 50% formamide, 2× SSC for 5 min and once in 1× SSC for 5 min in a 37OC humid chamber 617 
before DAPI staining as above.  618 
 619 
RNAi experiments 620 
The siRNA targeting human Ki-67 is from the collection of Silencer Select Predesigned 621 
siRNAs (Thermo Fisher Scientific), and targets nucleotides 559-577 of the cDNA 622 
(NM_002417.4). 623 
Its sequence is as follows:  624 
sense CGUCGUGUCUCAAGAUCUAtt,  625 
antisense UAGAUCUUGAGACACGACGtg 626 
TP53 (NM_00546.5) 627 
Forward primer for hTP53: GAAAUUUGCGUGUGGAGUAtt 628 
Reverse primer for hTP53:UACUCCACACGCAAAUUUCct 629 
p21(NM_078467.2) 630 
Forward primer for hp21: CAAGGAGUCAGACAUUUUAtt 631 
Reverse primer for hp21: UAAAAUGUCUGACUCCUUGtt 632 
 633 
esiRNA targeting human Ki-67 was generated by in vitro RNaseIII cleavage of T7 RNA 634 
polymerase-synthesized transcripts, as previously described (21,67), and targets internal 635 
repeat regions at nucleotides 3611-4047, 3979-4357, 4705-5098 and 6913-7347 of the 636 
cDNA (NM_002417.4). 637 
Forward primer for hKi-67  638 
gcgtaatacgactcactataggGTGCTGCCGGTTAAGTTCTCT 639 
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Reverse primer for hKi-67 640 
gcgtaatacgactcactataggGCTCCAACAAGCACAAAGCAA 641 
Forward primer for luciferase  642 
gcgtaatacgactcactataggAACAATTGCTTTTACAGATGC 643 
Reverse primer for luciferase 644 
gcgtaatacgactcactataggAGGCAGACCAGTAGATCC 645 
Cells were transfected with Lipofectamine RNAi MAX (Invitrogen Catalog number 646 
13778100) following manufacturer’s instructions.  647 
For esiRNA transfection, 500ng of esiRNA targeting either luciferase control or Ki-67 was 648 
transfected into 40 × 103 cells in a 6-well dish. 649 
For siRNA transfection, 40 nM of either scramble or siKi-67 was transfected into 40 × 103 650 
cells in a 6-well dish. 651 
The cells were harvested 72 hrs after transfection for immunoblotting, RT-qPCR, RNA-seq, 652 
FACS or FISH analysis.  653 
 654 
Flow cytometry 655 
BrdU incorporation was analyzed based on published prototcols (68). Cells were pulsed 656 
labeled with 50 μM bromodexoyuridine (BrdU) for the indicated time periods. Cells were 657 
then washed twice with PBS and fixed in 70% ethanol at 4OC for 1 hour. Post-fixed cells 658 
were denatured in 2N HCl/0.5% Triton-X for 30 minutes. After denaturation, cells were 659 
washed once in 0.1 M sodium tetraborate for 2 minutes and once in PBS/1% BSA. After 660 
that, cells were resuspended in 1 μg/ml anti-BrdU antibody/PBS/1% BSA for 1 hr, followed 661 
by three washes with 0.5% Tween 20/1% BSA/PBS. The cells were incubated with 0.5 662 
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μg/ml secondary antibody/PBS/1% BSA for 30 minutes and counterstained with 50 μg/ml 663 
propidium iodide / PBS and analyzed on a LSR II (BD Biosciences). The data was analyzed 664 
with FlowJo v9.9.4 software (TreeStar, Ashland, OR). 665 
 666 
RNA isolation and real time quantitative PCR 667 
Total RNA from cells 72 hours post-transfection was isolated using Trizol (Invitrogen 668 
15596026) following manufacturer’s instructions and purified using the RNeasy kit 669 
(Qiagen 74104).  670 
One microgram of RNA was subjected to reverse transcription with SuperScript II Reverse 671 
Transcriptase (Invitrogen 18064014). qPCR reactions were performed on an Applied 672 
Biosystem StepOnePlus machine (Life Technologies) using FAST SYBR mix (KAPA 673 
Biosystem).  The program used is as follows: hold 98°C for 30 s, followed by 40 cycles of 674 
95°C for 10 s and 60°C for 30 s. All the signals were normalized with beta-actin as indicated 675 
in the figure legends and the 2−ΔΔCt method was used for quantification (Life technologies). 676 
Primer sequences are designed by Primer3Plus software (69). All oligonucleotides for 677 
qPCR are listed in Supplemental Table 5. 678 
 679 
RNAseq: sample preparation and analysis 680 
RNA was isolated as described above. Libraries from two replicates for each condition were 681 
constructed in a strand-specific manner via the dUTP method by BGI and sequenced using 682 
Illumina-HiSeq 2000/2500 platform (BGI) as single-end 50-base reads.  29M and 31M 683 
mapped reads were obtained from two si-scramble-treated controls, 28M and 29M were 684 
obtained from two siKi-67 knockdown replicates.  685 
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Reads were aligned to the human reference genome (hg19) using Tophat 2.0.14 (70,71). 686 
Differential expression analysis was determined by Cufflinks 2.2.1 (72). In addition, the 687 
Reactome analyses were performed using Bioconductor package ChIPpeakAnno (version 688 
3.2.0)(73,74). Genes that showed differential expression with BH-adjusted q value < 0.05 689 
(75) between control and Ki-67 depletion samples were selected for the Reactome analysis.  690 
 691 
For the SNP analysis, the genotype (SNPs) information of the RPE cell line (76) from GEO 692 
sample GSM1848919. 693 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM1848919) was annotated 694 
based on R bioconductor package "SNPlocs.Hsapiens.dbSNP144.GRCh38". 695 
SNPlocs.Hsapiens.dbSNP144.GRCh38: SNP locations for Homo sapiens (dbSNP Build 144). R 696 
package version 0.99.20.) The SNP locations were further annotated by ChipPeakAnno 697 
package (73). 698 
  699 
Accession Numbers 700 
The data discussed in this publication have been deposited in NCBI's Sequence Read 701 
Archive (SRA, http://www.ncbi.nlm.nih.gov/sra/) and are accessible through SRA Series 702 
accession number SRR4252548. 703 
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Figure Legends 940 
 941 
Figure 1. Ki-67 depletion in hTERT-RPE1 cells reduced S-phase-related mRNA 942 
abundance and the proportion of cells in S phase. 943 
A. Scatter plot analysis of RNA levels, comparing two replicate si-scramble RNAseq 944 
analyses of hTERT-RPE1 cells. R: Pearson’s correlation coefficient. 945 
B. Scatter plot analysis comparing two replicate siKi-67 RNAseq analyses.  946 
C. Distribution of RNA level fold changes (FC) measured by RNAseq, comparing si-947 
scramble and siKi-67-treated hTERT-RPE1 cells. The x-axis shows the mean log2 value 948 
for normalized counts of abundance levels for each RNA species. The y-axis shows the 949 
log2 fold change upon Ki-67 depletion. The symmetry of the plot above and below the y 950 
= 0 axis indicates that similar numbers of genes are up- and down-regulated upon Ki-67 951 
depletion. 952 
D. Reactome evaluation of RNAseq analysis of si-Ki-67-treated cells.  The PATH terms with 953 
a p-value < 5e-05 are graphed. 954 
E. RNA levels of DNA replication genes are coordinately down-regulated in siKi-67-treated 955 
cells. RT-qPCR measurements are presented as fold change relative to the scramble 956 
siRNA control after normalization. MKI67 mRNA levels indicate effectiveness of the 957 
siRNA treatment. Data are mean ± std. dev. of 3 biological replicates. 958 
F. Analysis of RNA levels as in panel E, except that cells were treated with in vitro-diced 959 
esiRNAs as depletion reagents.  960 
G. FACS analysis of siRNA-treated cells. Cells were pulsed with BrdU for 20 min, and 961 
analyzed via two-dimensional flow cytometry monitoring BrdU incorporation (y-axis) 962 
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and DNA content (x-axis). G1 (lower left), G2 (lower right), and S-phase populations 963 
(upper box) are boxed in each sample, with percentages of the total population shown. 964 
Data shown are from one representative experiment of three biological replicates 965 
performed. 966 
H. FACS analysis as in panel G, except that cells were treated with esiRNAs. 967 
I. Quantification of percentage of cells in S-phase in siRNA-treated hTERT-RPE1 968 
populations from three biological replicate BrdU-labeling experiments. p-value 969 
comparing si-scramble and si-Ki-67 treatments is indicated, calculated via an unpaired, 970 
two-tailed parametric t test. 971 
J. Quantification of percentage of cells in G1 or G2/M phase from the same three 972 
experiments analyzed in panel I. 973 
K. Quantification of percentage of S-phase cells as in panel I, except that cells were treated 974 
with in vitro-diced esiRNAs. 975 
L.  Quantification of percentage of cells in G1 or G2/M phase from the same three 976 
experiments analyzed in panel K. 977 
M. Immunoblot analysis of Ki-67 depletion in siRNA-treated hTERT-RPE1 cells from panel 978 
D. Marker molecular weights are indicated on the left.  979 
N. Immunoblot analysis of Ki-67 depletion in esiRNA-treated hTERT-RPE1 cells from 980 
panel F.  981 
 982 
Figure 2. Validation of specificity and effectiveness of Ki-67 depletion reagents. 983 
A.  CRISPR/Cas9-based strategy for generating siRNA-resistant mutations in the 984 
endogenous Ki-67 gene. The si-Ki-67 target (green) and sgRNA-directed cleavage site 985 
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(red triangle) are indicated on the upper diagram of the endogenous locus. Altered 986 
nucleotides (red) and the novel EcoO109I restriction site are shown on the lower 987 
diagram of the repair template. 988 
B. DNA sequence analysis of a PCR product from wild-type hTERT-RPE1 cells and si-Ki-67-989 
resistant clone #7. 990 
C. EcoO109I digestion of the same PCR product sequenced in panel B.  991 
D. Immunoblot analysis of clone #7 treated with the indicated reagents. 992 
E. RT-qPCR analysis of clone #7.  993 
F-L. Immunoblot analyses of the indicated cell lines, treated with the indicated RNA 994 
depletion reagents. 995 
 996 
Figure 3. siRNA-mediated Ki-67 depletion affected S-phase gene expression and cell 997 
cycle distribution in diploid human cells.  998 
WI-38 (panels A-D), IMR-90 (panels E-H), hTERT-BJ (panels I-L) cell lines and human 999 
primary fibroblasts (HFF, panels M-P) were analyzed. 1000 
A, E, I, M.   RT-qPCR analysis, as in Figure 1E. 1001 
B, F, J, N.   FACS analysis, as in Figure 1G. 1002 
C, G, K, O.   Quantification of percentage of S-phase cells, as in Figure 1I. 1003 
D, H, L, P.  Quantification of percentage of G1 and G2/M phase cells as in Figure 1J. 1004 
 1005 
Figure 4. esiRNA-mediated depletion of Ki-67 in diploid cells resulted in the same 1006 
phenotypes observed with siRNA treatments. Cells and assays were the same as in 1007 
Figure 3.  1008 
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 1009 
Figure 5. Ki-67-insensitive cells. Ki-67 depletion did not affect S-phase gene expression 1010 
and cell cycle distribution in HeLa (panels A-D), U2OS (panels E-H), and 293T (panels I-L) 1011 
cell lines. Panels A, E, I:  RT-qPCR analysis. Panels B, F, J:  FACS analysis. Panels C, G, K:  1012 
Quantification of percentage of S-phase cells.  Panels D, H, L: Quantification of percentage of 1013 
G1 and G2/M phase cells. 1014 
 1015 
Figure 6. esiRNA-mediated depletion of Ki-67 in insensitive-cells resulted in the 1016 
same phenotypes observed with siRNA treatments. Cells and assays were the same as 1017 
in Figure 5. 1018 
 1019 
Figure 7. Depletion of Ki-67 delayed S-phase entry in hTERT-RPE1 cells.  1020 
A. Schematic of short-pulse assay. hTERT-RPE1 cells were released from HU arrest for the 1021 
indicated time periods, pulsed for 20 min with EdU, and analyzed by click chemistry 1022 
and fluorescence microscopy for EdU incorporation.  1023 
B. Representative cells from the indicated time points, showing EdU staining (green) to 1024 
detect the progression of S phase. Total DNA was visualized with DAPI staining (blue). S 1025 
phase cells were categorized into 3 sub-stages based on the number, size, shape and 1026 
distribution of fluorescent-labeled replication foci. During early S phase, small and 1027 
numerous replication foci were scattered in the nuclear interior, but excluded from 1028 
nucleolus, nuclear periphery and other heterochromatic regions. At mid-S phase, 1029 
replication takes place at the nuclear periphery and perinucleolar regions. Late in S 1030 
phase, there are several large foci throughout the nucleus (25).  Scale bar: 5 μm. 1031 
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C. Distributions of EdU morphologies during the time course. Percentages of early S phase, 1032 
middle S phase and late S phase EdU staining morphologies were counted in >300 total 1033 
cells per time point. 1034 
D. FACS histograms showing cell-cycle profiles of propidium-iodide stained hTERT-RPE1 1035 
cells. Asy: Asynchronous cells were incubated with DMSO vehicle control. HU block: 1036 
cells were incubated with hydroxyurea. Left panel: si-scramble-treated cells were 1037 
incubated with or without 2mM hydroxyurea for 15 hours. Right panel: siKi-67-treated 1038 
cells were incubated with or without 2mM hydroxyurea for 15 hours. Histograms were 1039 
generated using FlowJo v9.9.4. 1040 
E. A longer (three hour) EdU pulse prevents detection of S phase alterations in Ki-67-1041 
depleted hTERT-RPE1 cells. Asynchronous cells were treated with either si-scramble or 1042 
siKi-67 for 72 hrs, incubated with 5-ethynyl-2-deoxyuridine (EdU) for the final 3 hours, 1043 
and analyzed via click chemistry. The total cells assayed = 218 for si-scramble and 265 1044 
for siKi-67, in three independent experiments.  Scale bar, 20 μm  1045 
F. Ratio of EdU-positive cells to the total cell numbers. ns: not significant (p-value = 0.77). 1046 
G. Cell cycle distribution of the si-scramble and siKi-67 treated hTERT-RPE1 cells as 1047 
analyzed by one-dimensional FACS profiling of propidium iodide-stained cells. 1048 
 1049 
Figure 8. Rb contributes to transcriptional downregulation caused by Ki67 depletion. 1050 
A.  Summary of transcriptional changes of cell cycle target genes (based on Table S10 in 1051 
(26)). The “Adjusted Cell Cycle Score” on the y-axis indicates values based on meta-1052 
analysis of 5 different cell cycle expression data sets, plus information regarding 1053 
binding by Rb/E2F and MMB/FOXM1 transcription factors. Negative values indicate 1054 
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frequent detection of G1/S expression and binding by Rb/E2F, and positive values 1055 
indicate frequent detection of G2/M expression and binding by MMB-FOXM1.  1056 
B. p-values of transcription changes of E2F target genes (based on Table S9 in (26)), with 1057 
the greater score on the x-axis representing higher frequency of detection as an E2F 1058 
target. As expected from panel A, E2F targets are commonly downregulated upon Ki-67 1059 
depletion.  1060 
C. Immunoblot analysis hTERT-RPE1 Tet-sh-Rb cells. Cells were treated with either 1061 
vehicle (Rb+) or 2 μg/ml doxycycline (Rb-) as indicated for 72 h to induce sh-Rb 1062 
expression, and were also incubated in the presence of either si-scramble (Ki-67+) or 1063 
siKi-67 (Ki-67-).  1064 
D. RT-qPCR analysis of DNA replication genes in cells treated as in panel C. Measurements 1065 
are presented as fold change relative to the scramble siRNA control without 1066 
doxycycline induction. Data are mean ± std. dev. of 3 biological replicates. p-values were 1067 
calculated via unpaired, two-tailed parametric t tests and corrected for multiple 1068 
comparisons using the Holm-Sidak method.  1069 
E. Percentage of S phase cells calculated from three BrdU labeling experiments. p-values 1070 
were calculated via unpaired, two-tailed parametric t tests. 1071 
F. FACS analysis of a representative BrdU labeling experiment. 1072 
G. p-values of transcription changes of DREAM target genes (based on Table S7 in (26)), 1073 
with the greater score on the x-axis representing more frequent detection as a DREAM 1074 
target.  1075 
H. Model. In “Ki-67 sensitive” cells, depletion of Ki67 leads to p21 induction.  The elevated 1076 
p21 levels are predicted to downregulate the Rb/E2F and DREAM target G1/S cell cycle 1077 
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genes and inhibit DNA synthesis by binding to PCNA. Together, these effects delay S 1078 
phase entry. 1079 
Figure 9. Cell-type-specific induction of a p21-dependent checkpoint upon depletion 1080 
of Ki-67.  1081 
A. RT-qPCR analysis demonstrates cell-type specific induction of CDKN1A (p21) RNA upon 1082 
Ki-67 depletion. (left panel) Indicated cells were treated with either si-scramble or si-1083 
Ki-67 for 72 hrs. (right panel) Same, except cells were treated with esiRNAs. 1084 
B. Cell-type specific induction of p21 protein levels upon Ki-67 depletion.  hTERT-RPE1 1085 
and 293T cells were treated with the indicated siRNA or in vitro-diced esiRNA depletion 1086 
reagents.  p21 protein levels were quantified as a ratio to β-tubulin and normalized to 1087 
levels in control-treated cells. Quantification was done in Image J 10.2. 1088 
C. Immunoblot analysis of hTERT-RPE1 cells depleted of the indicated proteins via siRNA 1089 
treatments. Marker molecular weights are indicated on the right.  1090 
D. RT-qPCR analysis of DNA replication genes in hTERT-RPE1 cells from panel C. Asterisks 1091 
indicate values in the si-p21 + si-Ki-67 samples that were significantly different (p < 1092 
0.05) from the siKi-67 samples. p-values were calculated via unpaired, two-tailed 1093 
parametric t tests and corrected for multiple comparisons using the Holm-Sidak 1094 
method.  1095 
E. Percentage of S phase cells calculated from three BrdU labeling experiments. p-values 1096 
were calculated via unpaired, two-tailed parametric t tests. 1097 
F. FACS analysis of a representative BrdU labeling experiment. 1098 
G. Immunoblot analysis of additional siRNA-treated cell lines testing for p21 induction. 1099 
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H. RT-qPCR analysis of the indicated genes in MCF7 cells. p-values calculated as in panel D 1100 
were < 0.05 for all genes.  1101 
I. RT-qPCR analysis of the indicated genes in MDA-MB-231 cells.   1102 
J. RT-qPCR analysis of the indicated genes in HCT-116 cells.  1103 
 1104 
 1105 
Figure 10.  H3K27me3 and H4K20me1 staining of the inactive X chromosome was 1106 
altered upon Ki-67 depletion in a subset of hTERT-RPE1 cells. Scale bars, 5 μm. 1107 
A. Immuno-FISH analysis of H3K27me3 overlap with XIST in siRNA-treated hTERT-RPE1 1108 
cells. Note that in the si-Ki-67-treated cell, the H3K27me3 signal overlapping XIST 1109 
displayed reduced intensity and was localized away from the nuclear lamina.  1110 
B. Quantitation of percentage of cells that display reduced H3K27me3 enrichment on the 1111 
Xi in the panel A experiments. Enrichment was calculated as the ratio of the mean 1112 
H3K27me3 signal overlapping XIST divided by the mean H3K27me3 signal from 1113 
remainder of the entire nucleus. Cells with ratios less than 1.5 were defined as having 1114 
reduced enrichment, as described previously (48). Percentages were calculated for the 1115 
total cell populations, as well as for the nuclear lamina-associated XIST foci and the 1116 
non-lamina-associated foci, as indicated. Total cells assayed = 250 for si-scramble and 1117 
239 for si-Ki-67. Mean and SDs are graphed from three biological replicate experiments. 1118 
p-values were determined by unpaired student’s t tests.  1119 
C. Analysis of H3K27me3 enrichment on Xi as in panel A, for hTERT-RPE1 cells treated 1120 
with in vitro-diced esiRNAs. 1121 
D. Quantitation as in panel B. Total cells assayed= 236 for esi-luciferase, 220 for esi-Ki-67.  1122 
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E. Immuno-FISH analysis of H4K20me1 overlap with XIST in siRNA-treated hTERT-RPE1 1123 
cells. Note that the H4K20me1 signal colocalizing with XIST is reduced in the Ki-67-1124 
depleted cell. 1125 
F. Quantitation of the panel E experiments, as in panel B.  The total cells assayed = 204 si-1126 
scramble and 216 for si-Ki-67. 1127 
G. Analysis of H4K20me1 in cells treated with esiRNAs.  1128 
H. Quantitation of the panel G experiments. Total cells assayed = 164 for esi-luciferase, 1129 
182 for esi-Ki-67.  1130 
I. Example of H3K27me3 signal intensity quantification. 1131 
J. RT-qPCR analysis of XIST RNA levels in hTERT-RPE1 cells.  1132 
 1133 
Figure 11. H3K27me3 and H4K20me1 staining of the inactive X chromosome was 1134 
unaltered upon Ki-67 depletion in 293T cells. Scale bars, 5 μm. 1135 
A. Immuno-FISH analysis of H3K27me3 overlap with XIST in siRNA-treated 293T cells. 1136 
Note that 293T cells have two Xi chromosomes. In these cells, the H3K27me3 foci 1137 
overlapping XIST remained unchanged upon Ki67 depletion.  1138 
B. Quantitation of panel A. The total alleles assayed = 136 for si-scramble and 146 for si-1139 
Ki-67.  1140 
C, D. Analysis of H3K27me3 in esiRNA-treated 293T cells. Total alleles assayed = 196 for 1141 
esi-luciferase, 198 for esi-Ki-67.  1142 
E. Immuno-FISH analysis of H4K20me1 overlap with XIST in 293T cells.  In these cells, the 1143 
H4K20me1 foci overlapping XIST remained unchanged upon Ki67 depletion.  1144 
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F. Quantitation of panel E. The total alleles assayed = 180 for si-scramble and 162 for si-1145 
Ki-67.  1146 
G, H. Analysis of H4K20me1 in esiRNA-treated cells. Total alleles assayed = 180 for esi-1147 
luciferase, 162 for esi-Ki-67.  1148 
 1149 
Figure 12. Analysis of Cot-1 and Pol II enrichment on Xi in siRNA-treated hTERT-1150 
RPE1 cells. Scale bars, 5 μm. 1151 
A-B Localization of Cot-1-hybridizing transcripts relative to XIST domains, when XIST is 1152 
localized away from (A) or at (B) the nuclear lamina. A line scan (white arrow) across 1153 
the XIST signal (green) was used to analyze Cot-1 hybridization levels (red); 1154 
fluorescent densities across the line scan were plotted in the right-hand panels. Cot-1 1155 
RNA was considered to be reduced across the XIST domain when the average Cot-1 1156 
signal overlapping XIST was lower than the average Cot-1 signal across the nucleus. 1157 
The average nucleus Cot-1 signal is depicted in dotted line. In the examples shown 1158 
where Xi was within the cell interior (panel A), Cot-1 RNA was excluded from XIST in 1159 
the si-scramble-treated cell, but not the siKi-67-treated cell. In contrast, siKi-67 1160 
treatment did not affect Cot-1 enrichment on Xi in cells where Xi was at the lamina 1161 
(panel B).  1162 
C-D Analysis of RNA Pol II localization (red) relative to XIST (green) when XIST is localized 1163 
away from (panel C) or at (panel D) the nuclear lamina. Exclusion was analyzed as in 1164 
panels A-B. 1165 
E. Quantitation of Cot-1 RNA overlap with XIST RNA domains. Mean (and std. dev.) 1166 
percent of cells displaying Cot-1 RNA overlapping XIST foci are plotted from three 1167 
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biological replicate experiments. The total cells assayed = 404 for si-scramble and 465 1168 
for si-Ki-67. p-values were determined by unpaired student’s t tests.  1169 
F. Quantitation of percentage of cells showing presence of RNA Pol II at Xist RNA domain. 1170 
The total cells assayed = 362 for si-scramble and 367 for si-Ki-67. 1171 
G. Immunoblot analysis of Ki67 depletion in siRNA-treated hTERT-RPE1 cells from above. 1172 
 1173 
Figure 13.  Analysis of Cot-1 and Pol II enrichment on Xi in esiRNA-treated hTERT-1174 
RPE1 cells. Analyses were performed as in Figure 12. Scale bars, 5 μm. 1175 
A, B.  Cot-1. Total cells assayed= 178 for esi-luciferase, 180 for esi-Ki-67. 1176 
C, D.  Pol II. Total cells assayed= 160 for esi-luciferase, 176 for esi-Ki-67.  1177 
E. Quantitation of Cot-1 RNA overlap with XIST RNA domains from panels A-B.  1178 
F. Quantitation of RNA Pol II at Xist RNA domain from panels C-D. 1179 
G. Immunoblot analysis of Ki-67 depletion in esiRNA-treated hTERT-RPE1 cells from 1180 
above. 1181 
 1182 
Figure 14. Some aspects of Xi structure and function were resistant to Ki-67 1183 
depletion.  1184 
A. XIST cloud in hTERT-RPE1 cells has similar appearance regardless of Ki-67 depletion. 1185 
Cells were treated with the indicated siRNAs for 72 hrs and analyzed by RNA-FISH to 1186 
localize XIST (green) and DAPI staining (blue).  Scale bar: 10 μm. 1187 
B.  Average RNA levels of X linked genes did not change upon Ki-67 depletion in hTERT-1188 
RPE1 cells. log2 FPKM analyses of RNA-seq data from two biological replicates for the 1189 
two indicated siRNA treatments are shown.  1190 
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C-H.  MacroH2A enrichment at the XIST domain was not altered upon Ki-67 depletion. 1191 
hTERT-RPE1 cells were treated with siRNAs (C-E) or in vitro-diced esiKi-67 (F-H) for 72 1192 
hrs.  Panels C, F: Cells were analyzed by immuno-RNA-FISH to localize XIST (green) and 1193 
macroH2A (red). Scale bar: 10 μm. Panels D, G: Quantitation of cells that displayed reduced 1194 
macroH2A staining is shown. Total cells assayed= 248 for si-scramble, 291 for siKi-67, 218 1195 
for esi-luciferase, 236 for esiKi-67. Panels E, H: immunoblot analyses of Ki-67 depletions.  1196 
 1197 
 1198 
Figure 15.  Depletion of Ki-67 redistributed the Xi chromosome within hTERT-RPE1 1199 
but not 293T nuclei. Scale bars, 10 μm. 1200 
A. Fluorescence microscopy images of representative hTERT-RPE1 cells treated either 1201 
with scramble control or Ki-67-targeted siRNAs as indicated. Cells were analyzed by RNA-1202 
FISH to detect XIST RNA (green) marking the Xi, and by immunofluorescence with anti-1203 
fibrillarin antibodies (red) to label nucleoli. DNA was stained with DAPI (blue).  1204 
B. Quantification of XIST association frequencies from panel A experiments. XIST 1205 
associations with the indicated locations were counted; “total nucleolar” indicates the sum 1206 
of XIST signals that are exclusively nucleolar plus those that also are on the nuclear 1207 
periphery. Three biological replicate experiments were performed with mean percentage 1208 
association and SDs graphed. Total cells assayed = 363 for si-scramble, 376 for siKi-67. 1209 
Holm-Sidak corrected p-values comparing si-scramble and siKi-67 treatments are 1210 
indicated, with p-values < 0.05 in red. 1211 
C. Fluorescence microscopy images of representative hTERT-RPE1 cells treated either 1212 
with luciferase- or Ki-67-targeted esiRNAs as indicated. Cells were stained as in panel A.  1213 
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D. Quantification of association frequencies from panel C experiments. Total cells assayed 1214 
= 348 for esi-luciferase, 391 for esiKi-67. 1215 
E. Fluorescence microscopy images of representative 293T cells treated either with 1216 
scramble control or Ki-67-targeted siRNAs.   1217 
F. Quantification of XIST association frequencies from panel E experiments. Total alleles 1218 
assayed = 272 for si-scramble, 298 for siKi-67.  Holm-Sidak adjusted p-values comparing 1219 
association frequencies were > 0.97 for all comparisons.  1220 
G. Fluorescence microscopy images of representative 293T cells as panel E, except that 1221 
cells were treated with in vitro-diced esiRNAs as depletion reagents. 1222 
H. Quantitation of XIST association frequencies from panel G experiments.  1223 
Total alleles assayed = 250 for esi-luciferase, 270 for esiKi-67.  Holm-Sidak adjusted p-1224 
values comparing association frequencies were > 0.98 for all comparisons.  1225 
Panels I-L: Frequencies of Xi associations versus time. All associations were measured in 1226 
HU-synchronized cells as in Fig. 7A-B, with the averages and std. dev. from 3 independent 1227 
experiments. At each time point, >300 cells were counted. 1228 
I.  Xi-nucleolar only associations (Xi chromosomes associated with nucleoli but not lamina).  1229 
J. Xi chromosomes associated with both the lamina and nucleoli simultaneously. 1230 
K. Xi-lamina only associations (Xi chromosomes associated with lamina but not nucleoli). 1231 
Note that Xi-nucleolar associations (panels I-J) peak and Xi-lamina only (panel K) 1232 
associations reach a minimum when the majority of cells are in mid-late S phase, which is 1233 
delayed in Ki67-depleted cells by 2 hr. 1234 
L.  Xi-total laminar associations (Xi chromosomes associated either with the lamina or with 1235 
both lamina and nucleoli simultaneously). 1236 
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Legends for Supplemental tables 1237 
Supplemental Table 1. Top reactomes detected in siKi-67 RNAseq data. 1238 
Reactome analysis of transcriptional changes reveals functional grouping of pathways 1239 
altered upon Ki67 depletion in hTERT-RPE1 cells. Table shows all pathways enriched with 1240 
p value < 5 x 10-5. Log2FC value for selected DNA replication-related genes are shown at 1241 
the bottom 1242 
 1243 
Supplemental Table 2. Complete RNA-seq data from siRNA-treated hTERT-RPE1 1244 
cells. 1245 
Each transcript that mapped uniquely to the genome is listed. Value 1 is the mean FPKM 1246 
from two biological replicates in si-scramble-treated hTERT-RPE1 cells. Value 2 is the 1247 
mean FPKM from two biological replicates in siKi-67-treated hTERT-RPE1 cells. Fold 1248 
change is the ratio of value 2 over value1 in log2 range. Status, Test_stat, p_value and q_ 1249 
value are generated from Cufflinks 2.2.1(1). Status: “OK” indicates a successful test, 1250 
“NOTEST” indicates insufficient alignments for testing. Test_stat: displays the significance 1251 
of the observed change in FPKM. p_value: uncorrected  p-values of the test statistic. 1252 
q_value: p-value adjusted by the false discovery rate (FDR). The criteria of significance is 1253 
defined as q < 0.05.  1254 
 1255 
Supplemental Table 3. Comparison of our si-Ki-67 RNAseq data to meta-analyses of cell 1256 
cycle regulators (2). Separate sheets for the Cell cycle, E2F, and DREAM data are included.  1257 
Cell cycle: The “Adjusted Cell Cycle Score” equals the Cell cycle expression score (Negative 1258 
for G1/S-expressed genes, positive for G2/M-expressed genes, Table S10 in (2)), + 1 point 1259 
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for regulation by G2/M regulator MMB/FOXM1, -1 point for regulation by G1/S regulators 1260 
Rb/E2F. “si-Ki-67 log2FC” and “q-values” are from the RNAseq analysis of hTERT-RPE1 1261 
cells (Figure 1). Genes with the same Adjusted Cell Cycle score were analyzed in the same 1262 
bin. “Significant upregulation” was TRUE if the log2FC>0 AND q<0.05. “Significant 1263 
downregulation” was TRUE if log2FC<0 AND q<0.05. Benjamini-adjusted p-values (3) for 1264 
these enrichments were calculated and graphed in Figure 8. 1265 
E2F: The Rb/E2F binding scores come from Table S9 of (2). 1266 
DREAM: The DREAM binding scores come from Table S7 of (2). 1267 
 1268 
Supplemental Table 4. Analysis of X-linked SNPs in the RNAseq data. 1269 
The RNAseq analyses of hTERT-RPE1 cells were compared to SNPs from the genome 1270 
sequence these cells (4). We also compared these data to previous analysis of escapers 1271 
from Xi silencing  (5, 6).  1272 
 1273 
Supplemental Table 5. Oligonucleotides used in this study 1274 
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